Introduction of Protein S100 in Diagnostics in Minor Brain Injury Patients at Our Hospital

NCT01122212 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 128

Last updated 2015-04-21

No results posted yet for this study

Summary

In Patients with minor head injury measurement of protein S100 will be introduced to the emergency departement as another tool to rule out intracerebral bleeding.

Conditions

  • Intracerebral Hemorrhage

Sponsors & Collaborators

  • Roche Diagnostic Ltd.

    collaborator INDUSTRY
  • Kantonsspital Münsterlingen

    lead OTHER

Principal Investigators

  • Martin Blay, MD · Kantonsspital Münsterlingen

Eligibility

Min Age
4 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2010-07-31
Completion
2011-01-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01122212 on ClinicalTrials.gov